<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Surfbird Money</title><link>https://surfbirdmoney.com/</link><description>When money changes hands (an IPO lockup, an acquisition, an IRS deadline), get the dates, the numbers and the tax rules, checked against the source.</description><item><title>Valaris Ltd acquisition by Transocean Ltd.</title><link>https://surfbirdmoney.com/deals/valaris-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/valaris-acquisition-stock-options-rsus/</guid><description>Transocean is acquiring Valaris in an all-stock deal at 15.235 Transocean shares per Valaris share; Valaris shareholders voted in June 2026. Valaris RSUs are settled in Transocean shares at the same ratio, net of tax withholding. The value tracks Transocean&#x27;s share price.</description></item><item><title>Chemomab Therapeutics Ltd. reverse merger with Scipher Medicine Corporation</title><link>https://surfbirdmoney.com/deals/chemomab-therapeutics-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/chemomab-therapeutics-acquisition-stock-options-rsus/</guid><description>Chemomab is combining with privately held Scipher Medicine in a reverse merger, so Scipher&#x27;s business continues as the public company. Existing Chemomab holders, and holders of vested options, get one contingent value right (CVR) per share tied to the legacy business. This is not a cash buyout; the shareholder meeting is December 4, 2026.</description></item><item><title>DoubleDown Interactive Co., Ltd. acquisition by DoubleU Games Co., Ltd.</title><link>https://surfbirdmoney.com/deals/doubledown-interactive-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/doubledown-interactive-acquisition-stock-options-rsus/</guid><description>DoubleU Games, which already controls DoubleDown Interactive, is making a tender offer at $16.25 per ADS in cash to take the company private. DoubleDown says it has never granted options, RSUs or other equity awards, so this affects shareholders, not employee equity.</description></item><item><title>Micware Co., Ltd. IPO lockup ends November 13, 2026</title><link>https://surfbirdmoney.com/lockups/micware-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/micware-ipo-lockup-expiration/</guid><description>Micware Co., Ltd. (MWC) priced its IPO at $8.00 a share on May 13, 2026. The 6-month lockup on pre-IPO holders ends November 13, 2026, so locked shares can generally be sold from November 14, 2026 unless the underwriters release them earlier.  Officers, directors and 5% holders agreed to a six-month lockup.</description></item><item><title>INNIO N.V. IPO lockup ends November 30, 2026</title><link>https://surfbirdmoney.com/lockups/innio-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/innio-ipo-lockup-expiration/</guid><description>INNIO N.V. (INIO) priced its IPO at $27.00 a share on June 3, 2026. The 180-day lockup on pre-IPO holders ends November 30, 2026, so locked shares can generally be sold from December 1, 2026 unless the underwriters release them earlier.</description></item><item><title>DPC Holdings Ltd IPO lockup ends December 21, 2026</title><link>https://surfbirdmoney.com/lockups/dpc-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/dpc-ipo-lockup-expiration/</guid><description>DPC Holdings Ltd (DPC) priced its IPO at $33.00 a share on June 24, 2026. The 180-day lockup on pre-IPO holders ends December 21, 2026, so locked shares can generally be sold from December 22, 2026 unless the underwriters release them earlier.</description></item><item><title>Sinda Ltd. IPO lockup ends December 22, 2026</title><link>https://surfbirdmoney.com/lockups/sinda-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/sinda-ipo-lockup-expiration/</guid><description>Sinda Ltd. (SIND) priced its IPO at $12.00 a share on June 25, 2026. The 180-day lockup on pre-IPO holders ends December 22, 2026, so locked shares can generally be sold from December 23, 2026 unless the underwriters release them earlier.</description></item><item><title>Bending Spoons S.p.A. IPO lockup ends December 27, 2026</title><link>https://surfbirdmoney.com/lockups/bending-spoons-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/bending-spoons-ipo-lockup-expiration/</guid><description>Bending Spoons S.p.A. (BSP) priced its IPO at $29.00 a share on June 30, 2026. The 180-day lockup on pre-IPO holders ends December 27, 2026, so locked shares can generally be sold from December 28, 2026 unless the underwriters release them earlier.  The lockup can end early: 48 hours after the company publishes its second quarterly earnings report following the IPO, if that comes before day 180.</description></item><item><title>Ticketplus Ltd. IPO lockup ends February 2, 2027</title><link>https://surfbirdmoney.com/lockups/ticketplus-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/ticketplus-ipo-lockup-expiration/</guid><description>Ticketplus Ltd. (TP) priced its IPO at $8.00 a share on August 6, 2026. The 180-day lockup on pre-IPO holders ends February 2, 2027, so locked shares can generally be sold from February 3, 2027 unless the underwriters release them earlier.</description></item><item><title>SunScout Holding Ltd IPO lockup ends February 11, 2027</title><link>https://surfbirdmoney.com/lockups/sunscout-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/sunscout-ipo-lockup-expiration/</guid><description>SunScout Holding Ltd (SNSC) priced its IPO at $5.00 a share on August 11, 2026. The 6-month lockup on pre-IPO holders ends February 11, 2027, so locked shares can generally be sold from February 12, 2027 unless the underwriters release them earlier.  Directors, officers and certain shareholders agreed to a six-month lockup from the prospectus date.</description></item><item><title>Windward Bio Group AG IPO lockup ends May 11, 2027</title><link>https://surfbirdmoney.com/lockups/windward-bio-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/windward-bio-ipo-lockup-expiration/</guid><description>Windward Bio Group AG (WWB) priced its IPO at $17.00 a share on November 12, 2026. The 180-day lockup on pre-IPO holders ends May 11, 2027, so locked shares can generally be sold from May 12, 2027 unless the underwriters release them earlier.</description></item><item><title>vVARDIS Holding AG IPO lockup ends May 11, 2027</title><link>https://surfbirdmoney.com/lockups/vvardis-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/vvardis-ipo-lockup-expiration/</guid><description>vVARDIS Holding AG (VVVV) priced its IPO at $18.00 a share on November 12, 2026. The 180-day lockup on pre-IPO holders ends May 11, 2027, so locked shares can generally be sold from May 12, 2027 unless the underwriters release them earlier. The co-founders and their affiliated entities are locked for 270 days.</description></item><item><title>Aytu BioPharma acquisition by Rosemont Pharmaceuticals Holdings, Inc.</title><link>https://surfbirdmoney.com/deals/aytu-biopharma-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/aytu-biopharma-acquisition-stock-options-rsus/</guid><description>Aytu BioPharma agreed on November 16, 2026, to be acquired by Rosemont Pharmaceuticals through a tender offer at $2.70 per share in cash, to start within ten business days. Options vest in full and are cashed out at the spread over their exercise price.</description></item><item><title>Braze acquisition by Salesforce, Inc.</title><link>https://surfbirdmoney.com/deals/braze-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/braze-acquisition-stock-options-rsus/</guid><description>Salesforce agreed on October 19, 2026, to buy Braze for $47.50 per share in cash. Vested and director RSUs are paid $47.50 per share; unvested employee RSUs become Salesforce RSUs on the same vesting schedule; in-the-money options are cashed out.</description></item><item><title>Instacart (Maplebear) acquisition by DoorDash, Inc.</title><link>https://surfbirdmoney.com/deals/instacart-maplebear-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/instacart-maplebear-acquisition-stock-options-rsus/</guid><description>DoorDash agreed on October 28, 2026, to acquire Maplebear (Instacart). Each share can elect $65.00 in cash, 0.3372 DoorDash Class A share, or a mix of $48.75 cash plus 0.08430 DoorDash share, subject to proration; shares with no election receive cash. Employee RSU and PSU awards convert into DoorDash RSUs. The deal needs Instacart shareholder approval and antitrust clearance in the U.S. and other countries.</description></item><item><title>Rapid Micro Biosystems acquisition by Merck KGaA, Darmstadt, Germany</title><link>https://surfbirdmoney.com/deals/rapid-micro-biosystems-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/rapid-micro-biosystems-acquisition-stock-options-rsus/</guid><description>Merck KGaA, Darmstadt, Germany agreed on November 16, 2026, to buy Rapid Micro Biosystems through a tender offer at $0.75 per share in cash. Vested options and RSUs are cashed out at that price; unvested awards are converted to cash amounts based on it under the merger agreement.</description></item><item><title>Surgery Partners acquisition by Spyglass Topco, LLC</title><link>https://surfbirdmoney.com/deals/surgery-partners-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/surgery-partners-acquisition-stock-options-rsus/</guid><description>Surgery Partners agreed on October 23, 2026, to be acquired by Spyglass Topco, LLC, backed by Bon Secours Mercy Health, for $23.50 per share in cash. Some existing holders will roll their shares into the buyer instead of taking cash. In-the-money options vest and are cashed out at the spread.</description></item><item><title>Aspen Neuroscience, Inc. IPO lockup ends April 27, 2027</title><link>https://surfbirdmoney.com/lockups/aspen-neuroscience-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/aspen-neuroscience-ipo-lockup-expiration/</guid><description>Aspen Neuroscience, Inc. (ASPE) priced its IPO at $15.00 a share on October 29, 2026. The 180-day lockup on pre-IPO holders ends April 27, 2027, so locked shares can generally be sold from April 28, 2027 unless the underwriters release them earlier. About 19,703,600 shares (roughly $295.6 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Bambusa Therapeutics, Inc. IPO lockup ends April 27, 2027</title><link>https://surfbirdmoney.com/lockups/bambusa-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/bambusa-therapeutics-ipo-lockup-expiration/</guid><description>Bambusa Therapeutics, Inc. (BBTX) priced its IPO at $16.00 a share on October 29, 2026. The 180-day lockup on pre-IPO holders ends April 27, 2027, so locked shares can generally be sold from April 28, 2027 unless the underwriters release them earlier. About 40,386,875 shares (roughly $646.2 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>ADT acquisition by Abode Parent, LLC</title><link>https://surfbirdmoney.com/deals/adt-acquisition-stock-options-rsus/</link><guid>https://surfbirdmoney.com/deals/adt-acquisition-stock-options-rsus/</guid><description>ADT agreed on October 29, 2026, to be acquired by Abode Parent, LLC for $10.00 per share in cash. The deal needs a shareholder vote. Options and unvested RSUs become a contingent right to cash based on $10.00 per share; the contingent right generally keeps paying out on a schedule set in the merger agreement, so check the proxy when it is filed.</description></item><item><title>TRex Bio, Inc. IPO lockup ends April 6, 2027</title><link>https://surfbirdmoney.com/lockups/trex-bio-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/trex-bio-ipo-lockup-expiration/</guid><description>TRex Bio, Inc. (TRXB) priced its IPO at $14.00 a share on October 8, 2026. The 180-day lockup on pre-IPO holders ends April 6, 2027, so locked shares can generally be sold from April 7, 2027 unless the underwriters release them earlier. About 19,112,348 shares (roughly $267.6 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Amaero Inc. IPO lockup ends April 12, 2027</title><link>https://surfbirdmoney.com/lockups/amaero-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/amaero-ipo-lockup-expiration/</guid><description>Amaero Inc. (AMRO) priced its IPO at $4.25 a share on October 14, 2026. The 180-day lockup on pre-IPO holders ends April 12, 2027, so locked shares can generally be sold from April 13, 2027 unless the underwriters release them earlier. About 23,833,180 shares (roughly $101.3 million at the IPO price) were held by pre-IPO owners. The company itself is locked for 90 days; directors, officers and Pegasus are locked for 180 days.</description></item><item><title>Iambic Therapeutics, Inc. IPO lockup ends April 12, 2027</title><link>https://surfbirdmoney.com/lockups/iambic-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/iambic-therapeutics-ipo-lockup-expiration/</guid><description>Iambic Therapeutics, Inc. (IAM) priced its IPO at $16.00 a share on October 14, 2026. The 180-day lockup on pre-IPO holders ends April 12, 2027, so locked shares can generally be sold from April 13, 2027 unless the underwriters release them earlier. About 38,025,796 shares (roughly $608.4 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>City Therapeutics, Inc. IPO lockup ends April 13, 2027</title><link>https://surfbirdmoney.com/lockups/city-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/city-therapeutics-ipo-lockup-expiration/</guid><description>City Therapeutics, Inc. (CTY) priced its IPO at $18.00 a share on October 15, 2026. The 180-day lockup on pre-IPO holders ends April 13, 2027, so locked shares can generally be sold from April 14, 2027 unless the underwriters release them earlier. About 40,610,057 shares (roughly $731.0 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Lycia Therapeutics, Inc. IPO lockup ends April 20, 2027</title><link>https://surfbirdmoney.com/lockups/lycia-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/lycia-therapeutics-ipo-lockup-expiration/</guid><description>Lycia Therapeutics, Inc. (LYCA) priced its IPO at $18.00 a share on October 22, 2026. The 180-day lockup on pre-IPO holders ends April 20, 2027, so locked shares can generally be sold from April 21, 2027 unless the underwriters release them earlier. About 37,394,559 shares (roughly $673.1 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Electra Therapeutics, Inc. IPO lockup ends March 16, 2027</title><link>https://surfbirdmoney.com/lockups/electra-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/electra-therapeutics-ipo-lockup-expiration/</guid><description>Electra Therapeutics, Inc. (ETRA) priced its IPO at $15.00 a share on September 17, 2026. The 180-day lockup on pre-IPO holders ends March 16, 2027, so locked shares can generally be sold from March 17, 2027 unless the underwriters release them earlier. About 39,433,621 shares (roughly $591.5 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Orion180 Insurance Group Inc. IPO lockup ends March 16, 2027</title><link>https://surfbirdmoney.com/lockups/orion180-insurance-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/orion180-insurance-ipo-lockup-expiration/</guid><description>Orion180 Insurance Group Inc. (OIG) priced its IPO at $12.00 a share on September 17, 2026. The 180-day lockup on pre-IPO holders ends March 16, 2027, so locked shares can generally be sold from March 17, 2027 unless the underwriters release them earlier. About 79,032,452 shares (roughly $948.4 million at the IPO price) were held by pre-IPO owners across the share classes counted; the prospectus has more than one class, so this may be incomplete.</description></item><item><title>ADARx Pharmaceuticals, Inc. IPO lockup ends March 23, 2027</title><link>https://surfbirdmoney.com/lockups/adarx-pharmaceuticals-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/adarx-pharmaceuticals-ipo-lockup-expiration/</guid><description>ADARx Pharmaceuticals, Inc. (ADRX) priced its IPO at $17.00 a share on September 24, 2026. The 180-day lockup on pre-IPO holders ends March 23, 2027, so locked shares can generally be sold from March 24, 2027 unless the underwriters release them earlier. About 80,551,325 shares (roughly $1.37 billion at the IPO price) were held by pre-IPO owners.</description></item><item><title>Accelevation Holdings Corp. IPO lockup ends March 1, 2027</title><link>https://surfbirdmoney.com/lockups/accelevation-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/accelevation-ipo-lockup-expiration/</guid><description>Accelevation Holdings Corp. (ACCV) priced its IPO at $18.00 a share on September 2, 2026. The 180-day lockup on pre-IPO holders ends March 1, 2027, so locked shares can generally be sold from March 2, 2027 unless the underwriters release them earlier. About 90,022,472 shares (roughly $1.62 billion at the IPO price) were held by pre-IPO owners across the share classes counted; the prospectus has more than one class, so this may be incomplete.</description></item><item><title>Retension Pharmaceuticals, Inc. IPO lockup ends April 6, 2027</title><link>https://surfbirdmoney.com/lockups/retension-pharmaceuticals-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/retension-pharmaceuticals-ipo-lockup-expiration/</guid><description>Retension Pharmaceuticals, Inc. (RTSN) priced its IPO at $12.00 a share on October 8, 2026. The 180-day lockup on pre-IPO holders ends April 6, 2027, so locked shares can generally be sold from April 7, 2027 unless the underwriters release them earlier. About 4,581,599 shares (roughly $55.0 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Londian Wason New Energy Tech Inc. IPO lockup ends February 7, 2027</title><link>https://surfbirdmoney.com/lockups/londian-wason-new-energy-tech-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/londian-wason-new-energy-tech-ipo-lockup-expiration/</guid><description>Londian Wason New Energy Tech Inc. (FOIL) priced its IPO at $22.00 a share on August 11, 2026. The 180-day lockup on pre-IPO holders ends February 7, 2027, so locked shares can generally be sold from February 8, 2027 unless the underwriters release them earlier.</description></item><item><title>Braveheart Bio, Inc. IPO lockup ends February 1, 2027</title><link>https://surfbirdmoney.com/lockups/braveheart-bio-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/braveheart-bio-ipo-lockup-expiration/</guid><description>Braveheart Bio, Inc. (BRVE) priced its IPO at $18.00 a share on August 5, 2026. The 180-day lockup on pre-IPO holders ends February 1, 2027, so locked shares can generally be sold from February 2, 2027 unless the underwriters release them earlier. About 51,902,838 shares (roughly $934.3 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>BlossomHill Therapeutics, Inc. IPO lockup ends February 2, 2027</title><link>https://surfbirdmoney.com/lockups/blossomhill-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/blossomhill-therapeutics-ipo-lockup-expiration/</guid><description>BlossomHill Therapeutics, Inc. (BLSM) priced its IPO at $16.00 a share on August 6, 2026. The 180-day lockup on pre-IPO holders ends February 2, 2027, so locked shares can generally be sold from February 3, 2027 unless the underwriters release them earlier. About 21,268,660 shares (roughly $340.3 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Latigo Biotherapeutics, Inc. IPO lockup ends February 2, 2027</title><link>https://surfbirdmoney.com/lockups/latigo-biotherapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/latigo-biotherapeutics-ipo-lockup-expiration/</guid><description>Latigo Biotherapeutics, Inc. (LTGO) priced its IPO at $18.00 a share on August 6, 2026. The 180-day lockup on pre-IPO holders ends February 2, 2027, so locked shares can generally be sold from February 3, 2027 unless the underwriters release them earlier. About 44,038,030 shares (roughly $792.7 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Vogenx, Inc. IPO lockup ends February 7, 2027</title><link>https://surfbirdmoney.com/lockups/vogenx-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/vogenx-ipo-lockup-expiration/</guid><description>Vogenx, Inc. (VOGX) priced its IPO at $13.00 a share on August 11, 2026. The 180-day lockup on pre-IPO holders ends February 7, 2027, so locked shares can generally be sold from February 8, 2027 unless the underwriters release them earlier. About 7,667,587 shares (roughly $99.7 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Reformation Inc. IPO lockup ends January 25, 2027</title><link>https://surfbirdmoney.com/lockups/reformation-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/reformation-ipo-lockup-expiration/</guid><description>Reformation Inc. (REF) priced its IPO at $15.00 a share on July 29, 2026. The 180-day lockup on pre-IPO holders ends January 25, 2027, so locked shares can generally be sold from January 26, 2027 unless the underwriters release them earlier. About 45,013,708 shares (roughly $675.2 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Apnimed, Inc. IPO lockup ends January 26, 2027</title><link>https://surfbirdmoney.com/lockups/apnimed-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/apnimed-ipo-lockup-expiration/</guid><description>Apnimed, Inc. (APMD) priced its IPO at $16.00 a share on July 30, 2026. The 180-day lockup on pre-IPO holders ends January 26, 2027, so locked shares can generally be sold from January 27, 2027 unless the underwriters release them earlier. About 27,823,183 shares (roughly $445.2 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Jersey Mike&#x27;s Subs Inc. IPO lockup ends January 25, 2027</title><link>https://surfbirdmoney.com/lockups/jersey-mike-s-subs-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/jersey-mike-s-subs-ipo-lockup-expiration/</guid><description>Jersey Mike&#x27;s Subs Inc. (JMKE) priced its IPO at $23.00 a share on July 29, 2026. The 180-day lockup on pre-IPO holders ends January 25, 2027, so locked shares can generally be sold from January 26, 2027 unless the underwriters release them earlier. About 274,160,639 shares (roughly $6.31 billion at the IPO price) were held by pre-IPO owners across the share classes counted; the prospectus has more than one class, so this may be incomplete.</description></item><item><title>Attovia Therapeutics, Inc. IPO lockup ends January 31, 2027</title><link>https://surfbirdmoney.com/lockups/attovia-therapeutics-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/attovia-therapeutics-ipo-lockup-expiration/</guid><description>Attovia Therapeutics, Inc. (ATTO) priced its IPO at $17.00 a share on August 4, 2026. The 180-day lockup on pre-IPO holders ends January 31, 2027, so locked shares can generally be sold from February 1, 2027 unless the underwriters release them earlier. About 26,029,017 shares (roughly $442.5 million at the IPO price) were held by pre-IPO owners.</description></item><item><title>Csquare, Inc. IPO lockup ends January 11, 2027</title><link>https://surfbirdmoney.com/lockups/csquare-ipo-lockup-expiration/</link><guid>https://surfbirdmoney.com/lockups/csquare-ipo-lockup-expiration/</guid><description>Csquare, Inc. (CSQR) priced its IPO at $21.00 a share on July 15, 2026. The 180-day lockup on pre-IPO holders ends January 11, 2027, so locked shares can generally be sold from January 12, 2027 unless the underwriters release them earlier.</description></item></channel></rss>